Locally delivered salicylic acid from a poly(anhydride-ester): Impact on diabetic bone regeneration

Journal of Controlled Release

Volumn 171, Issue 1, 2013, Pages 33-37

  Wada, Keisuke ^a   Yu, Weiling ^b   Elazizi, Mohamad ^a   Barakat, Sandrine ^a   Ouimet, Michelle A ^c   Rosario Meléndez, Roselin ^c   Fiorellini, Joseph P ^a   Graves, Dana T ^a   Uhrich, Kathryn E ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Bone regeneration; Diabetes; Poly(anhydride ester); Salicylic acid

Indexed keywords

BONE; COMPUTERIZED TOMOGRAPHY; DEFECTS; ESTERS; MEDICAL PROBLEMS; PATHOLOGY; RATS;

BONE REGENERATION; CRITICAL SIZED DEFECTS; DIABETES MELLITUS; INFLAMMATORY RESPONSE; MANDIBULAR ANGLES; MICROCOMPUTED TOMOGRAPHY; POLY(ANHYDRIDE-ESTER); SPRAGUE-DAWLEY RATS;

SALICYLIC ACID;

POLY(ANHYDRIDE ESTER); POLYMER; SALICYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE GRAFT; BONE REGENERATION; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; HYPERGLYCEMIA; INFLAMMATION; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOTOMY; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; ULTRAVIOLET SPECTROPHOTOMETRY;

BONE REGENERATION; DIABETES; POLY(ANHYDRIDE-ESTER); SALICYLIC ACID;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BONE REGENERATION; BONE TRANSPLANTATION; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, EXPERIMENTAL; ESTERS; MALE; MANDIBLE; POLYANHYDRIDES; RATS; RATS, SPRAGUE-DAWLEY; SALICYLIC ACID; X-RAY MICROTOMOGRAPHY;

EID: 84885092281     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.06.024     Document Type: Article

References (42)

1. American Diabetes Association, Diabetes Facts Sheet, 2011.
2. D.T. Graves, RA Kayal, Diabetic complications and dysregulated innate immunity, Front. Biosci. 13 (2008) 1227-1239. (Pubitemid 351594707)
3. B. Ponugoti, G. Dong, D.T. Graves, Role of forkhead transcription factors in diabetes-induced oxidative stress, Exp. Diabetes Res. (2012) 939751.
4. S. Adami, Bone health in diabetes: considerations for clinical management, Curr. Med. Res. Opin. 25 (2009) 1057-1072.
5. L Claes, S. Recknagel, A. Ignatius, Fracture healing under healthy and inflammatory conditions, Nat Rev. Rheumatol. 8 (2012) 133-143.
6. H. Lu, D. Kraut, L Gerstenfeld, D.T. Graves, Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation, Endocrinology 144 (2003) 346-352. (Pubitemid 36076124)
7. S. Pacios, J. Kang, J. Galicia, K. Gluck, H. Patel, A. Ovaydi-Mandel, S. Petrov, F. Alawi, D.T. Graves, Diabetes aggravates periodontitis by limiting repair through enhanced inflammation, FASEB 26 (2012) 1423-1430.
8. F.C. Sasso, D. Torella, O. Carbonara, G.M. Ellison, M. Torella, M. Scardone, C. Marra, R Nasti, R. Marfella, D. Cozzolino, C Indolfi, M. Cotrufo, R. Torella, T. Salvatore, Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease, J. Am. Coll. Cardiol. 46 (2005) 827-834. (Pubitemid 41224806)
9. M. Hie, I. Tsukamoto, Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes, Int J. Mol. Med. 26 (2010) 611-618.
10. RA Kayal, D. Tsatsas, MA Bauer, B. Allen, M.O. Al-Sebaei, S. Kakar, C.W. Leone, E.F. Morgan, LC. Gerstenfeld, TA Einhorn, D.T. Graves, Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity, J. Bone Miner. Res. 22 (2007) 560-568. (Pubitemid 47457433)
11. R. Liu, H. Bal, T. Desta, N. Krothapalli, M. Alyassi, Q. Luan, D.T. Graves, Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation, J. Dent Res. 85 (2006) 510-514. (Pubitemid 43945487)
12. H. Dinopoulos, R. Dimitriou, P.V. Giannoudis, Bone graft substitutes: what are the options? Surgeon 10 (2012) 230-239.
13. G. Semb, Alveolar bone grafting, Front. Oral Biol. 169 (2012) 124-136.
14. M. Retzepi, M.P. Lewis, N. Donos, Effect of diabetes and metabolic control on de novo bone formation following guided bone regeneration, Clin. Oral Implants Res. 21 (2010) 71-79.
15. C.L. Ramanujam, Z. Facaros, T. Zgonis, An overview of bone grafting techniques for the diabetic Charcot foot and ankle, Clin. Podiatr. Med. Surg. 29 (2012) 589-595.
16. A.P. White, A.R. Vaccaro, J.A. Hall, P.G. Whang, B.C. Friel, M.D. McKee, Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion, Int. Orthop. 31 (2007) 735-741. (Pubitemid 350160312)
17. J.P. Fiorellini, T.H. Howell, D. Cochran, J. Malmquist, L.C. Lilly, D. Spagnoli, J. Toljanic, A. Jones, M. Nevins, Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation, J. Periodontol. 76 (2005) 605-613. (Pubitemid 40711289)
18. P.V. Govender, Y.R. Rampersaud, L. Rickards, M.G. Fehlings, Use of osteogenic protein-1 in spinal fusion: literature review and preliminary results in a prospective series of high-risk cases, Neurosurg. Focus. 13 (2002).
19. K.R. Garrison, S. Donell, J. Ryder, I. Shemilt, M. Mugford, I. Harvey, F. Song, Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review, Health Technol. Assess. 11 (2007) 1-150.
20. L. Erdmann, K.E. Uhrich, Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters), Biomaterials 21 (2000) 1941-1946. (Pubitemid 30433822)
21. R.C. Schmeltzer, K.E. Schmalenberg, K.E. Uhrich, Synthesis and cytotoxicity of salicylate-based poly(anhydride esters), Biomacromolecules 6 (2005) 359-367. (Pubitemid 40277034)
22. L. Erdmann, B. Macedo, K.E. Uhrich, Degradable poly(anhydride ester) implants: effects of localized salicylic acid release on bone, Biomaterials 21 (2000) 2507-2512.
23. J.N. Housby, C.M. Cahil, B. Chu, R. Prevelige, K. Bickford, M.A. Stevenson, S.K. Calderwood, Non-steroidal anti-inflammatory drugs inhibit the expression of cyto-kines and induce HSP70 in human monocytes, Cytokine 11 (1999) 347-358. (Pubitemid 29233968)
24. D. Fujita, N. Yamashita, S. Iita, H. Amano, S. Yamada, K. Sakamoto, Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells, Prostaglandins Leukot. Essent. Fatty Acids 68 (2003) 351-358. (Pubitemid 36535261)
25. R. Gruber, F. Karreth, M.B. Fischer, G. Watzek, Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism, Bone 30 (2002) 726-732. (Pubitemid 34467994)
26. C. Lader, A. Flanagan, Prostaglandin E2, interleukin 1 alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro, Endocrinology 139 (1998) 3157-3164. (Pubitemid 28512345)
27. Y. Okada, J.A. Lorenzo, A.M. Freeman, M. Tomita, S.G. Morham, L.G. Raisz, C.C. Pilbeam, Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture, J. Clin. Invest. 105 (2000) 823-832. (Pubitemid 30164121)
28. R.C. Schmeltzer, T.J. Anastasiou, K.E. Uhrich, Optimized synthesis of salicylate-based poly(anhydride-esters), Polym. Bull. 49 (2003) 441-448.
29. K. Whitaker-Brothers, K.E. Uhrich, Investigation into the erosion mechanism of salicylate-based poly(anhydride-esters), J. Biomed. Mater. Res. A 76 (2006) 470-479.
30. A. Göpferich, J. Tessmar, Polyanhydride degradation and erosion, Adv. Drug Deliv. Rev. 54 (2006) 911-931.
31. A. Khan, U. Wilson, Reactive oxygen species as cellular messengers, Curr. Biol. 2 (1995) 437-445.
32. R. Dimitriou, E. Tsiridis, P.V. Giannoudis, Current concepts of molecular aspects of bone healing, Int. J. Care Inj. 36 (2005) 1392-1404. (Pubitemid 41618169)
33. J. Vane, R. Botting, Inflammation and the mechanism of action of anti-inflammatory drugs, J. Fed. Am. Soc. Exp. Biol. 1 (1987) 89-96. (Pubitemid 18057324)
34. T. Suzawa, C. Miyaura, M. Inada, T. Maruyama, Y. Sugimoty, R. Ushikubi, A. Ichikawa, S. Narumiya, T. Suda, The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs, Endocrinology 141 (2000) 1554-1559. (Pubitemid 32269125)
35. Y. Morinaga, N. Fujita, K. Ohishi, Y. Zhang, T. Tsuruo, Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors, J. Cell. Physiol. 175 (1998) 247-254. (Pubitemid 28198204)
36. W.S.S. Jee, R.F. Ma, The in vivo anabolic actions of prostaglandins in bone, Bone 21 (1997) 297-304. (Pubitemid 27454082)
37. K.A. Blackwell, L.G. Raisz, C.C. Pilbeam, Prostaglandins in bone: bad cop, good cop? Trends Endocrinol. Metab. 21 (2010) 294-301.
38. D.J. Simmons, Fracture healing perspectives, Clin. Orthop. 200 (1985) 100-113. (Pubitemid 16138037)
39. M.A. Reynolds, A. Prudencio, M.E. Aichelmann-Reidy, K. Woodward, K.E. Uhrich, Non-steroidal anti-inflammatory drug (NSAID)-derived poly(anhydride-esters) in bone and periodontal regeneration, Curr. Drug Deliv. 4 (2007) 233-239. (Pubitemid 47025407)
40. L. Erdmann, B. Macedo, K.E. Uhrich, Degradable poly(anhydride ester) implants: effects of localized salicylic acid release on bone, Biomaterials 21 (2000) 2507-2512.
41. R.D. Harten, D.J. Svach, R. Schmeltzer, K.E. Uhrich, Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo, J. Biomed. Mater. Res. 72A (2005) 354-362. (Pubitemid 40315849)
42. J. Cottrell, J.P. O'Connor, Effect of non-steroidal anti-inflammatory drugs on bone healing, Pharmaceuticals 3 (2010) 1668-1693.